JS

Joseph Sullivan

Chief Executive Officer at Auravax Therapeutics, Inc.

Joseph Sullivan has an extensive work experience spanning several companies and roles. Joseph is currently the Chief Executive Officer of Auravax Theurapeutics, Inc., a company they joined in 2023. Prior to that, they served as the Chief Commercial Officer at Nature's Toolbox (NTx) from 2020 to 2023. At NTx, they were responsible for overseeing the development and production of mRNA and protein-based vaccines and medicines.

Before their role at NTx, Joseph was a Co-founder of Gypsy Basin Genomics, Inc. from 2019 to 2023. Gypsy Basin Genomics focused on commercializing a molecular diagnostic for detecting cervical and other HPV-related precancer and cancer. During their time there, Joseph played a key role in improving the diagnostic and prognostic results of DNA screening.

Joseph's earlier experience includes working at IMV Inc. as the Senior Vice President of Business Development from 2018 to 2020. Joseph also held various positions at Merck & Co, Inc., including Executive Director of Vaccine Partner Strategy and Implementation Lead from 2011 to 2018, Executive Director of the New Vaccines Product Group from 2006 to 2011, and Executive Director of the HPV Franchise from 2004 to 2006.

Joseph's career at Merck & Co, Inc. started in 1991, where they held roles such as Senior Director of the Dermatology Franchise in 2004, Senior Director of the Respiratory Franchise from 1999 to 2004, Sales & Marketing Director at MSD Philippines from 1997 to 1999, Director of Business Planning & Market Research from 1996 to 1997, Global Product Manager of Hepatitis B Vaccine from 1994 to 1996, and Marketing Analyst and Professional Representative from 1991 to 1993.

Throughout their career, Joseph has demonstrated expertise in business development, commercial strategy, marketing, and partnership management in the pharmaceutical and biotechnology industries.

Joseph Sullivan completed their Bachelor's Degree in Economics from Hamilton College, from the year 1980 to 1984. Later, they pursued an MBA from the Cornell Johnson Graduate School of Management, specializing in Marketing/Finance, however, the specific years for this degree are not provided.

Links

Previous companies

Merck logo

Org chart